You are here: Industry Insights > GSK

News List

GSK, Plasticell sign deal to produce haematopoietic cells pharmatimes
October 19, 2017
GlaxoSmithKline and Plasticell have signed a collaboration agreement to produce haematopoietic cells from induced pluripotent stem cells (iPSCs).
GSK collaborates with Plasticell for stem cell technology biospectrumasia
October 18, 2017
In the collaboration, Plasticell will use its CombiCult technology to screen combinations of molecules provided by GSK to identify and optimise iPSC differentiation protocols.
GSK’s Shingrix receives approval in Canada to prevent shingles pharmaceufical-technology
October 17, 2017
GlaxoSmithKline’s (GSK) non-live, recombinant sub-unit, adjuvanted vaccine Shingrix has received approval from Health Canada to prevent shingles (herpes zoster) in people aged 50 or older.
Ebola vaccines from GSK, Merck elicit yearlong response, study finds fiercepharma
October 16, 2017
After initially setting out to test two vaccines on 28,000 volunteers during West Africa's deadly Ebola epidemic, a U.S.-Liberia research team had to dramatically reduce its aspirations when the outbreak started coming to an end.
GSK ranked at bottom of ‘good governance’ report pharmafile
October 11, 2017
A new report emerging from the Institute of Directors placed UK pharma giant, GSK, in last place out of 103 companies in regards to its own specific criteria for good governance for UK companies.
GSK’s Benlysta receives Japanese MHLW approval for systemic lupus erythematosus pharmaceufical-technology
September 30, 2017
Indicated for patients who are inadequate responders to existing therapies, Benlysta is approved for use as an add-on therapy in autoantibody-positive SLE patients.
GSK receives Japanese nod for Benylsta biospectrumasia
September 28, 2017
Benlysta treats adult patients with systemic lupus erythematosus (SLE) who are inadequate responders to existing therapies
GSK joins AstraZeneca and Labcyte to develop acoustic mass spectrometry pharmaceufical-technology
September 25, 2017
GSK has joined forces with AstraZeneca and Labcyte to combine acoustic liquid dispensing technology with mass spectrometry (MS) for use in high throughput small molecule screening and other drug discovery applications.
Witty, Ex-CEO of GSK, keeps busy with two new roles in two days pharmafile
September 22, 2017
It was always unlikely that Andrew Witty, former CEO of GSK, would take his ‘retirement’ from the company literally, but he has stepped up his work after the company into a new gear, with two appointments in as many days.
GSK and Innoviva receive positive opinion from CHMP for Trelegy Ellipta to treat COPD pharmaceufical-technology
September 19, 2017
Trelegy Ellipta is the proposed brand name for fluticasone furoate / umeclidinium / vilanterol (FF / UMEC / VI), which is co-developed by GlaxoSmithKline (GSK) and Innoviva.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 40 41 Next page